Addex goes public
Zurich – Addex Pharmaceuticals has announced to go public at the SWX stock exchange. The former start-up said it plans to raise up to CHF155 million (a95 million), including an overallotment option of 15%, by issuing up to 2.7 million new registered shares. First day of trade should be May 22, the company said. Addex is focused on novel G-Protein Coupled Receptors (GPCRs) drugs.